Ocrelizumab-Induced Severe Colitis

We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis.

Detalles Bibliográficos
Autores principales: Lee, Hsing Hwa, Sritharan, Naveen, Bermingham, Daniel, Strey, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737437/
https://www.ncbi.nlm.nih.gov/pubmed/33354373
http://dx.doi.org/10.1155/2020/8858378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737437/
https://www.ncbi.nlm.nih.gov/pubmed/33354373
http://dx.doi.org/10.1155/2020/8858378

Ejemplares similares